| 05/02/25 | 07:00:07 | 5 Feb 2025 | | Shionogi reports positive RSV trial results |
| 03/02/25 | 07:00:07 | 3 Feb 2025 | | RSV contract signed with Inhalon Biopharma |
| 31/01/25 | 13:24:53 | 31 Jan 2025 | | Holding(s) in Company |
| 31/01/25 | 07:00:06 | 31 Jan 2025 | | Holding(s) in Company |
| 29/01/25 | 07:01:00 | 29 Jan 2025 | | Acquisition: two Clinical Research Units from CRS |
| 29/01/25 | 07:00:05 | 29 Jan 2025 | | Trading update |
| 27/01/25 | 07:00:06 | 27 Jan 2025 | | LOI signed for Phase 3 Whooping Cough trial |
| 21/01/25 | 07:00:04 | 21 Jan 2025 | | £3.2m hLAB project |
| 14/01/25 | 07:00:07 | 14 Jan 2025 | | Holding(s) in Company |
| 13/01/25 | 07:00:06 | 13 Jan 2025 | | hMPV challenge model update |
| 12/12/24 | 07:00:08 | 12 Dec 2024 | | COVID-19 study published in Nature Communications |
| 10/12/24 | 07:00:03 | 10 Dec 2024 | | £11.5m RSV contract and notice of trading update |
| 19/11/24 | 07:00:08 | 19 Nov 2024 | | Holding(s) in Company |
| 06/11/24 | 07:00:07 | 6 Nov 2024 | | Holding(s) in Company |
| 05/11/24 | 07:00:11 | 5 Nov 2024 | | Presentation at Jefferies London Healthcare Conf |
| 11/10/24 | 07:00:07 | 11 Oct 2024 | | Long Term Incentive Plan/ PDMR Notification |
| 07/10/24 | 07:00:09 | 7 Oct 2024 | | Positive results from RSV human challenge trial |
| 30/09/24 | 07:00:16 | 30 Sept 2024 | | Launch of full suite of hLAB standalone services |
| 24/09/24 | 07:00:12 | 24 Sept 2024 | | Holding(s) in Company |
| 17/09/24 | 07:00:09 | 17 Sept 2024 | | Holding(s) in Company |
| 13/09/24 | 07:00:08 | 13 Sept 2024 | | Holding(s) in Company |
| 10/09/24 | 07:00:05 | 10 Sept 2024 | | Interim results |
| 05/09/24 | 07:00:13 | 5 Sept 2024 | | Holding(s) in Company |
| 20/08/24 | 07:00:17 | 20 Aug 2024 | | Notice of results |
| 06/08/24 | 15:07:30 | 6 Aug 2024 | | Holding(s) in Company |
| 05/08/24 | 07:00:05 | 5 Aug 2024 | | Euronext cancellation |
| 24/07/24 | 13:55:33 | 24 Jul 2024 | | Holding(s) in Company |
| 23/07/24 | 14:48:49 | 23 Jul 2024 | | Director/PDMR Shareholding |
| 17/07/24 | 07:01:00 | 17 Jul 2024 | | Holding(s) in Company |
| 17/07/24 | 07:00:05 | 17 Jul 2024 | | Trading update |
| 08/07/24 | 07:00:12 | 8 Jul 2024 | | Holding(s) in Company |
| 03/07/24 | 14:48:45 | 3 Jul 2024 | | Holding(s) in Company |
| 02/07/24 | 07:02:00 | 2 Jul 2024 | | Change of registered address |
| 02/07/24 | 07:01:00 | 2 Jul 2024 | | Capital Markets Day & Notice of trading update |
| 02/07/24 | 07:00:09 | 2 Jul 2024 | | Influenza 2b field study contract |
| 03/06/24 | 07:00:06 | 3 Jun 2024 | | £2.5m contract for Omicron characterisation study |
| 13/05/24 | 13:02:44 | 13 May 2024 | | Result of AGM |
| 15/04/24 | 07:00:05 | 15 Apr 2024 | | Annual Report & Notice of AGM |
| 09/04/24 | 07:09:05 | 9 Apr 2024 | | Final results |
| 27/03/24 | 07:00:13 | 27 Mar 2024 | | Notice of Results |
| 22/03/24 | 15:03:54 | 22 Mar 2024 | | Holding(s) in Company |
| 14/03/24 | 07:00:10 | 14 Mar 2024 | | Holding(s) in Company |
| 15/02/24 | 07:00:06 | 15 Feb 2024 | | Long Term Incentive Plan / PDMR Notification |
| 14/02/24 | 13:14:06 | 14 Feb 2024 | | Result of Secondary Placing |
| 14/02/24 | 07:00:04 | 14 Feb 2024 | | Proposed Secondary Placing of Ordinary Shares |
| 02/02/24 | 12:44:52 | 2 Feb 2024 | | Holding(s) in Company |
| 30/01/24 | 07:00:05 | 30 Jan 2024 | | Trading update |
| 08/01/24 | 07:00:04 | 8 Jan 2024 | | Broker change |
| 02/01/24 | 07:00:04 | 2 Jan 2024 | | £6.3m HRV contract signed with biotech client |
| 13/12/23 | 07:00:10 | 13 Dec 2023 | | £16.8m RSV contract & Trading ahead of guidance |
